Nitric oxide synthase II mRNA expression in cardiac tissue of patients with heart failure undergoing cardiac transplantation

Journal of Heart and Lung Transplantation

Volumn 19, Issue 2, 2000, Pages 139-144

  Orús, Josefina ^b   Heras, Magda ^b   Morales Ruiz, Manuel ^a   Leivas, Alberto ^a   Roig, Eulàlia ^b   Rigol, Montserrat ^b   Rivera, Francisca ^b   Sanz, Ginés ^b   Jiménez, Wladimiro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; MESSENGER RNA; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD LEVEL; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; HEART DILATATION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VENTRICLE FAILURE; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARDIOMYOPATHY, DILATED; FEMALE; GENE EXPRESSION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0343048985     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00126-6     Document Type: Article

References (22)

1. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
2. Morris S.M., Billiar T.R. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 266:1994;E829-E839.
3. De Belder A., Radomski M., Why H., et al. Nitric oxide synthase activities in human myocardium. Lancet. 341:1993;84-85.
4. Finkel M., Oddis C., Jacob T., Watkins S., Hattler B., Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 257:1992;387-389.
5. Haywood G.A., Tsao P.H., Von der Leyen H.E., et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 93:1996;1087-1094.
6. Satoh M., Nakamura M., Tamura G., et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol. 29:1997;716-724.
7. Geller D.A., Lowenstein C.J., Shapiro R.A., et al. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci. 90:1993;3491-3495.
8. Ercolani L., Florence B., Denaro M., Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem. 263:1988;1535-1541.
9. Xie Q.W., Cho H.J., Calaycay J., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
10. Misko T.P., Schilling R.J., Salvemini D., et al. A fluorometric assay for the measurement of nitrite in biological samples. Biochemistry. 214:1993;11-16.
11. Dec G.W., Fuster V. Idiopathic dilated cardiomyopathy. New Engl J Med. 8:1994;1564-1575.
12. Bing R.J., Suzuki H. Myocardial infarction and nitric oxide. Mol Cell Biochem. 160:1996;303-306.
13. Baylis C., Vallance P. Measurement of nitrite and nitrate levels in plasma and urine, what does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens. 7:1998;59-62.
14. Stein B., Eschenhagen T., Rüdiger J., Scholz H., Förstermann U., Ingolf G. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II,in human heart failure. J Am Coll Cardiol. 32:1998;1179-1186.
15. Drexler H., Kästner S., Strobel A., Studer R., Brodde O., Hasenfuß G. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol. 32:1998;955-963.
16. Fukuchi M., Hussain S., Giaid A. Heterogeneous expression activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Circulation. 98:1998;132-139.
17. Winlaw D.S., Smythe G.A., Keogh A.M., Schyvens C.S., Spratt P.M., MacDonald P.S. Increased nitric oxide production in heart failure. Lancet. 344:1994;373-374.
18. Habib F., Dutka D., Crossman D., Oakley C.M., Cleland J.G.F. Enhanced basal nitric oxide production in heart failure another failed counter-regulatory vasodilator mechanism . Lancet. 344:1994;371-373.
19. Balligand J.L., Ungureanu-Longrois D., Simmons W.W., et al. Cytokine-inducible Nitric Oxide Synthase (iNOS) expression in cardiac myocytes. J Biol Chem. 1994;580-583.
20. Levine B., Kalman K., Mayer L., Fillit F., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
21. Roig E., Orús J., Paré C., et al. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 88:1998;686-690.
22. O'Driscoll L., Daly C., Saleh M., Clynes M. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrugresistant cells. Cytotechnology. 12:(1-3):1993;289-314.